Multiplex Assay Kit for Clusterin (CLU) ,etc. by CBA (Cytometric Bead Array)

CLU; TRPM2; KUB1; CLI; APOJ; SGP2; AAG4; APO-J; SP-40; Apolipoprotein J; Complement Lysis Inhibitor; 40,Sulfated Glycoprotein 2; Testosterone-Repressed Prostate Message 2

Specificity

This assay has high sensitivity and excellent specificity for detection of Clusterin (CLU) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Clusterin (CLU) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Clusterin (CLU) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Clusterin (CLU) ,etc. by CBA (Cytometric Bead Array) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 89-102 98
EDTA plasma(n=5) 98-105 101
heparin plasma(n=5) 98-105 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Clusterin (CLU) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Clusterin (CLU) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Clusterin (CLU) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 80-90% 80-95% 91-102% 84-96%
EDTA plasma(n=5) 91-103% 96-105% 78-96% 96-105%
heparin plasma(n=5) 92-99% 95-105% 91-101% 78-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Endocrinology Deficiency of Clusterin Exacerbates High-Fat Diet-Induced Insulin Resistance in Male Mice Pubmed: 24684302
J Mol Neurosci. Time-Dependent Decrease of Clusterin as a Potential Cerebrospinal Fluid Biomarker for Drug-Resistant Epilepsy. Pubmed: 24488574
PLOS ONE Serum Amyloid A and Clusterin as Potential Predictive Biomarkers for Severe Hand, Foot and Mouth Disease by 2D-DIGE Proteomics Analysis Pubmed:25268271
journal of immunological methods Proteomic analysis of human plasma and peripheral blood mononuclear cells in Systemic Lupus Erythematosus patients. pubmed:28390925
Journal of Alzheimer's Disease Proteomics Analysis of Blood Serums from Alzheimer's Disease Patients Using iTRAQ LabelingTechnology. pubmed:27911324
Biochimica Et Biophysica Acta Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells pubmed:28941799
World Neurosurgery Clusterin, a New Cerebrospinal Fluid Biomarker in Severe Subarachnoid Hemorrhage: A Pilot Study pubmed:28803177
BMC Cancer Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis Pubmed:29386009
Diabetes/metabolism research and reviews High serum clusterin levels are correlated with premature coronary artery disease in a Chinese population Pubmed: 30659732
Cancer Cell Int Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer 33602229
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB180Hu02 Recombinant Clusterin (CLU) Positive Control; Immunogen; SDS-PAGE; WB.
RPB180Hu01 Recombinant Clusterin (CLU) Positive Control; Immunogen; SDS-PAGE; WB.
PAB180Hu01 Polyclonal Antibody to Clusterin (CLU) WB; IHC
LAB180Hu81 FITC-Linked Polyclonal Antibody to Clusterin (CLU) WB; IHC; ICC; IF.
LAB180Hu71 Biotin-Linked Polyclonal Antibody to Clusterin (CLU) WB; IHC; ICC.
MAB180Hu23 Monoclonal Antibody to Clusterin (CLU) WB; ICC/IF
MAB180Hu22 Monoclonal Antibody to Clusterin (CLU) WB
MAB180Hu21 Monoclonal Antibody to Clusterin (CLU) WB; ICC/IF
FAB180Hu02 Anti-Clusterin (CLU) Monoclonal Antibody FCM
SEB180Hu ELISA Kit for Clusterin (CLU) Enzyme-linked immunosorbent assay for Antigen Detection.
CMB180Hu Multiplex Assay Kit for Clusterin (CLU) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.
LMB180Hu Multiplex Assay Kit for Clusterin (CLU) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSB180Hu01 ELISA Kit DIY Materials for Clusterin (CLU) Main materials for "Do It (ELISA Kit) Yourself".